Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed an outdated funding-status notice and an earlier revision note, representing site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoChange DetectedAdded a government-funding lapse notice and updated the page revision to v3.4.1; removed the previous revision v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedThis page update shows a system revision from v3.3.3 to v3.3.4 and does not modify study details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated to include a comprehensive list of trial site states; old state listings were removed and a new Revision: v3.3.3 tag appears.SummaryDifference2%

- Check92 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed, replacing the previous wording. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.